InDex Pharmaceuticals Holding AB announced that the company has appointed Eva Arlander as Chief Development Officer. Eva will also be part of the management team, together with acting Chief Executive Officer and Chief Financial Officer Johan Giléus, Chief Medical Officer Anders Bröijersén and Chief Scientific Officer Charlotte Admyre. Eva Arlander is a pharmacist and PhD in clinical pharmacology, and has previously held senior positions at Astra Zeneca, Medivir and Affibody with a main focus on clinical development, as well as department head at the Medical Products Agency.

Anders Bröijersén, who previously held the role of Senior Medical Director Clinical Operations at InDex, will take over as Chief Medical Officer after Thomas Knittel, who will continue to be engaged by the company as Senior Medical Consultant. Charlotte Admyre has worked at InDex for many years and has held several key positions in research and development, business development and investor relations.